Thrombolysis

Contributing journals to this collection:
JAMA & Archives Journals

Citations 261-270 of 392 total displayed.

Past content

Original Contributions
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

A. Michael Lincoff; John A. Bittl; Robert A. Harrington; Frederick Feit; Neal S. Kleiman; J. Daniel Jackman; Ian J. Sarembock; David J. Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A. Cohen; Amadeo Betriu; Walter Desmet; Dean J. Kereiakes; Wolfgang Rutsch; Robert G. Wilcox; Pim J. de Feyter; Alec Vahanian; Eric J. Topol; for the REPLACE-2 Investigators
JAMA 2003; 289: 853-863. [Abstract] [Full text] [PDF] [ Corrected PDF ]  

Editorials
Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?

Elliott M. Antman
JAMA 2003; 289: 903-905. [Extract] [Full text] [PDF]  

Original Articles
Follow-up of Infrainguinal Graft Thrombolysis: Analysis of Predictors of Clinical Success

Darryl A. Zuckerman; Mary G. Alderman; Mary C. Idso; Thomas K. Pilgram; Gregorio A. Sicard
Arch Surg 2003; 138: 198-202. [Abstract] [Full text] [PDF]  

Original Articles
The Effect of Subcutaneously Administered Low-Molecular-Weight Heparin on Microarterial Thrombosis in the Rat

Tessa A. Hadlock; Jennifer Kim; Daniel G. Deschler
Arch Facial Plast Surg 2003; 5: 36-39. [Abstract] [Full text] [PDF]  

Editorials
The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism

James E. Dalen
Arch Intern Med 2002; 162: 2521-2523. [Extract] [Full text] [PDF]  

Original Investigations
Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism: A Clinical Outcome–Based Meta-analysis

Giancarlo Agnelli; Cecilia Becattini; Timo Kirschstein
Arch Intern Med 2002; 162: 2537-2541. [Abstract] [Full text] [PDF]  

Original Investigations
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?

Jeff Nagge; Mark Crowther; Jack Hirsh
Arch Intern Med 2002; 162: 2605-2609. [Abstract] [Full text] [PDF]  

Original Contributions
Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction: GUSTO V Randomized Trial

A. Michael Lincoff; Robert M. Califf; Frans Van de Werf; James T. Willerson; Harvey D. White; Paul W. Armstrong; Victor Guetta; W. Brian Gibler; Judith S. Hochman; Christoph Bode; Alec Vahanian; P. Gabriel Steg; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E. Booth; Kathy Wolski; Michael Waller; Eric J. Topol; for the GUSTO V Investigators
JAMA 2002; 288: 2130-2135. [Abstract] [Full text] [PDF]  

Original Investigations
Extended Venous Thromboembolism Prophylaxis After Total Hip Replacement: A Comparison of Low-Molecular-Weight Heparin With Oral Anticoagulant

Charles Marc Samama; Muriel Vray; Jeanne Barré; Jean-Noël Fiessinger; Nadia Rosencher; Thomas Lecompte; Gérard Potron; Joseph Basile; Russell Hull; Denise Desmichels; for the SACRE Study Investigators
Arch Intern Med 2002; 162: 2191-2196. [Abstract] [Full text] [PDF]  

Original Investigations
Prolonged Thromboprophylaxis With Oral Anticoagulants After Total Hip Arthroplasty: A Prospective Controlled Randomized Study

Paolo Prandoni; Olinto Bruchi; Paola Sabbion; Cinzia Tanduo; Alberta Scudeller; Corrado Sardella; Gabriella Errigo; Francesco Pietrobelli; Gianni Maso; Antonio Girolami
Arch Intern Med 2002; 162: 1966-1971. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40